Monopar Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.0k | 1.5k | 0.68 |
| 2023-12-31 | $13 | 37 | 0.35 |
| 2023-09-30 | $20 | 33 | 0.61 |
| 2023-06-30 | $28 | 33 | 0.85 |
| 2022-12-31 | $72 | 31 | 2.35 |
| 2022-09-30 | $0 | 30 | 0.00 |
| 2022-06-30 | $0 | 29 | 0.00 |
| 2022-03-31 | $0 | 26 | 0.00 |
| 2021-12-31 | $0 | 26 | 0.00 |
| 2021-09-30 | $0 | 26 | 0.00 |
| 2021-06-30 | $0 | 27 | 0.00 |
| 2021-03-31 | $0 | 19 | 0.00 |
| 2020-12-31 | $0 | 19 | 0.00 |
| 2020-09-30 | $0 | 14 | 0.00 |